Skip to content

PressReach

SEARCH icon
  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos
Search

SEARCH FOR AN ARTICLE

  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos

PressReach

icon

      HomeBiotech

      Biotech

      Day One Reports Second Quarter 2022 Financial Results and Corporate Progress
      Biotech

      Day One Reports Second Quarter 2022 Financial Results and Corporate Progress

      August 18, 2022
      BioCryst Announces Approval of ORLADEYO® (berotralstat) in Saudi Arabia
      Biotech

      BioCryst Announces Approval of ORLADEYO® (berotralstat) in Saudi Arabia

      August 18, 2022
      Recursion Receives ISS ESG Prime Rating and Plans to Participate in the Goldman Sachs Global Sustainability Forum
      Biotech

      Recursion Receives ISS ESG Prime Rating and Plans to Participate in the Goldman Sachs Global Sustainability Forum

      August 18, 2022
      Cocrystal Pharma Engages CRO to Conduct Phase 2a Human Challenge Influenza A Clinical Trial with Novel, Broad-Spectrum Antiviral Candidate CC-42344
      Biotech

      Cocrystal Pharma Engages CRO to Conduct Phase 2a Human Challenge Influenza A Clinical Trial with Novel, Broad-Spectrum Antiviral Candidate CC-42344

      August 9, 2022
      Xenon Pharmaceuticals to Present at the 13th Annual Wedbush PacGrow Healthcare Conference
      Biotech

      Xenon Pharmaceuticals to Present at the 13th Annual Wedbush PacGrow Healthcare Conference

      August 9, 2022
      Veru Announces Presentation of Phase 3 Study of Sabizabulin for the Treatment of Hospitalized COVID-19 Patients at High Risk for Acute Respiratory Distress Syndrome at the 11th International Conference on Emerging Infectious Diseases (ICEID) on August 7-10, 2022
      Biotech

      Veru Announces Presentation of Phase 3 Study of Sabizabulin for the Treatment of Hospitalized COVID-19 Patients at High Risk for Acute Respiratory Distress Syndrome at the 11th International Conference on Emerging Infectious Diseases (ICEID) on August 7-10, 2022

      August 9, 2022
      ChemoCentryx Cancels Second Quarter 2022 Financial Results Conference Call
      Biotech

      ChemoCentryx Cancels Second Quarter 2022 Financial Results Conference Call

      August 9, 2022
      Heron Therapeutics Announces $76.5 Million Private Placement Financing
      Biotech

      Heron Therapeutics Announces $76.5 Million Private Placement Financing

      August 9, 2022
      Agios Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Chief Executive Officer
      Biotech

      Agios Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Chief Executive Officer

      August 9, 2022
      FibroGen Reports Second Quarter 2022 Financial Results
      Biotech

      FibroGen Reports Second Quarter 2022 Financial Results

      August 9, 2022
      « 1 … 119 120 121 122 123 … 134 »

       

      LATEST NEWS

      • Health Sanofi Market Potential Boosted by Amvuttra Data

      PressReach

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from PressReach.

      I want e-mail alerts, updates, and offers and agree to the PressReach privacy policy.

      Market Jar Media Inc. © 2026